Home-based cardiac rehabilitation with family empowerment for people after acute coronary syndrome
Official title: Development and Implementation Model of Home Based Cardiac Rehabilitation With Family Empowerment Approach in Patient With ACS (HBCR in ACS)
Run by Gadjah Mada University · NCT06625463 · Data updated 2026-11-12
This program will test whether a home-based cardiac rehab plan that trains and involves family members helps adults recovering from acute coronary syndrome improve exercise capacity and quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Gadjah Mada University Academic / other |
| Locations | 2 sites (Sleman, Special Region of Yogyakarta and 1 other locations) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | June 10, 2025 |
| Study ends | September 30, 2025 |
| Registry record updated | June 15, 2025 |
| Trial ID | NCT06625463 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–65 who were hospitalized for an acute coronary syndrome 3 months to 1 year earlier, live with family, are medically stable with no significant depression, and are willing to participate in a home-based rehab program.
✕Probably not a fit
Patients with serious comorbidities requiring routine medical care, unstable vital signs, severe depression, those who live alone, or people outside the 18–65 age range are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 18–65 who had an acute coronary syndrome 3 months to 1 year earlier and live with family are enrolled and assigned to receive either a home-based cardiac rehabilitation program with a family-centered empowerment approach or usual care. Baseline measures include a six-minute walk test to estimate peak VO2 and questionnaires for health-related quality of life, and the 6MWT results are used to set home exercise intensity. Family members receive structured education and support to help supervise and encourage the patient's home exercise and risk-factor management. Primary outcomes focus on changes in peak VO2 and patient-reported quality of life over the follow-up period.
Why it matters
Potential benefit: If successful, this approach could help patients recover more fitness and improve quality of life at home by leveraging family support.
How similar studies have gone: Prior research shows home-based cardiac rehabilitation can produce similar gains in fitness and quality of life as center-based programs, but combining it with a structured family empowerment model is less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with acute coronary syndrome who have undergone hospitalization, with a minimum home care time of 3 months and a maximum of 1 year, calculated from the day of discharge from the hospital until the time of interview. 2. Aged 18-65 years, participants were selected with age variations representing young adults, adults and the elderly. 3. Patients with first experience of SCA, participants were selected whether they had undergone PCI or not. 4. Patients living with family and family involved in the patient care process. 5. Physical condition allows for interviews. physical condition is evidenced by examination of stable vital signs (diastolic BP \>90, systolic \<150 mmhg; N: 60-100x/min; S: 36-380c, no pain). Psychological condition does not show symptoms of depression as measured by the Patient Health Questionnaire-9 instrument. 6. Willing to participate in the study. Exclusion Criteria: * Patients with comorbidities that require routine medication such as Diabetes Mellitus, hypertension, renal failure
Where it's running
-
Rsup Dr Sardjito
Yogyakarta, Special Region of Yogyakarta, Indonesia Recruiting -
Gadjah Mada University
Sleman, Special Region of Yogyakarta, Indonesia Not yet recruiting
Study contacts
- Study coordinator: Eva Marti, M.Kep
- Email: evamarti85@gmail.com
- Phone: +628963-6598-725
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Aspirin 50 mg vs 100 mg with a P2Y12 inhibitor after PCI
This trial tests whether a 50 mg daily aspirin dose, when used with a P2Y12 inhibitor after PCI, works as well as 100 mg with similar safety for people staying on DAPT for 12 months.
-
Early Triple Lipid-Lowering Therapy After ACS
This trial tests whether adding bempedoic acid to high-intensity statin and ezetimibe within 72 hours after PCI helps more adults with acute coronary syndrome reach LDL-C goals than the standard two-drug approach.
-
Smartphone AI help for prehospital ECG readings
This study tests whether using a smartphone AI (GPT-4o) to help prehospital providers read 12-lead ECGs improves accuracy in diagnosing acute coronary syndromes and related conditions.
-
Early single antiplatelet therapy after IVUS-guided PCI in ACS
This study tests whether stopping aspirin early and continuing a potent P2Y12 inhibitor alone is safe and effective after IVUS-guided PCI in people with acute coronary syndrome.
-
Local and systemic macrophage activation in coronary and peripheral artery disease
This study tests whether macrophage activity inside coronary and peripheral arteries relates to circulating monocyte subtypes in people with stable and acute artery disease.
-
Long-term P2Y12 inhibitor monotherapy and blood clotting after angioplasty
This trial will test whether specific P2Y12 drugs and reduced doses given alone keep platelet activity in a safe therapeutic range for people who completed initial dual antiplatelet therapy after PCI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.